.AN2 Rehabs is actually reviewing its organization in reaction to lackluster midphase data, swearing...
.Merck & Co. is actually paying out $700 million in advance to test Amgen in a blood cancer marke...
.With Gilead Sciences on the verge of an FDA decision for its liver ailment medication seladelpar, t...
.CEO David Ricks can easily find the business setting up tents at basecamp responsible for Eli Lilly...
.Mattress Liquidators has switched Entero Therapies white as a slab. The lender purchased Entero to ...
.Exelixis is actually giving up on its own cells factor (TF)- targeting antibody-drug conjugate afte...
.Three weeks after Roche's Genentech device walked away from an SHP2 prevention deal, Relay Rehab ha...
.Stoke Therapeutics' Dravet syndrome medicine has been actually devoid of a predisposed grip, cleari...
.Tough Biotech Colleague Publisher Gabrielle Masson showed the 2024 course of Tough 15 champions on ...
.Novo Nordisk has axed its own once-monthly dual GLP-1/ GIP receptor agonist, finishing (PDF) develo...